In 2013, an innovative neurology is emerging which is overcoming all kinds of hurdles: genetics, biotechnology, medical imaging, neurosurgery, the pharmaceutical industry… fundamental and clinical research are uniting
The shareholders of SCOR SE are hereby informed that the annual ordinary and extraordinary Shareholders’ Meeting will take place at 10:00 on Tuesday 6 May 2014 at the SCOR group’s headquarters.
SCOR Global Life, a subsidiary of SCOR SE, has entered into a VIF (Value of In-Force) monetization transaction with Mediterráneo Vida, a Spanish insurance company fully owned by Banco Sabadell.
Marie-Laurence Bouchon has joined SCOR as Head of Group Communications. Based in Paris, she is responsible for coordinating all facets of Group communication, both external and internal.
Marie-Laurence Bouchon has joined SCOR as Head of Group Communications. Based in Paris, she is responsible for coordinating all facets of Group communication, both external and internal.
SCOR Global Life, a subsidiary of SCOR SE, has entered into a longevity transaction with the UK-based insurer Aviva.
SCOR Global Life, a subsidiary of SCOR SE, has entered into a longevity transaction with the UK-based insurer Aviva.
SCOR's annual results of 2013.
SCOR posts record net income of EUR 549 million and an ROE of 11.5% in 2013, and proposes a dividend of EUR 1.30 per share1
SCOR Global P&C delivers strong January renewals with 5% premium growth and stable expected net technical profitability.
SCOR Global P&C delivers strong January renewals with 5% premium growth and stable expected net technical profitability.
SCOR Global P&C delivers strong January renewals with 5% premium growth and stable expected net technical profitability
